Search results
Results from the WOW.Com Content Network
Elon Musk’s brain implant company Neuralink revealed Tuesday that it will begin testing its medical device in human trials. The company announced that the human trials will be used to evaluate ...
The U.S. Food and Drug Administration has let Neuralink and its competitors test their implantable brain-computer interface (BCI) on motor function, enabling users to control a device by thinking.
Neuralink's tech could help study and treat neurological disorders. Musk also claims it could one day meld human consciousness with AI. Neuralink's first human patient has been revealed.
Neuralink received FDA approval for human clinical trials in May 2023. [90] The FDA had rejected a 2022 application to pursue human clinical trials, citing "major safety concerns involving the device's lithium battery; the potential for the implant's tiny wires to migrate to other areas of the brain; and questions over whether and how the ...
Noland Arbaugh (born 1993 or 1994) is an American quadriplegic known for being the first human recipient of Neuralink's brain-computer interface (BCI) implant. [1] He gained attention for his use of the device to regain digital autonomy after a spinal cord injury left him paralyzed.
The United States Food and Drug Administration's Investigational New Drug (IND) program is the means by which a pharmaceutical company obtains permission to start human clinical trials and to ship an experimental drug across state lines (usually to clinical investigators) before a marketing application for the drug has been approved.
Elon Musk’s controversial biotechnology startup Neuralink opened up recruitment for its first human clinical trial Tuesday, according to a company blog. Neuralink, Elon Musk’s brain implant ...
Neuralink, which first tested its device in monkeys and other animals, is now testing the device in humans. The company makes a brain-chip which enables paralyzed patients to control a computer ...